Abstract
Three men with non-ischemic cardiomyopathy and heart failure (HF) underwent HeartMate II (Thoratec, Pleasanton, CA) left ventricular assist device (LVAD) placement as a bridge to heart transplantation. At baseline, all patients had severe LV dilatation, LV systolic dysfunction, and mitral annular dilatation, but no historical or echocardiographic evidence of mitral valve prolapse (MVP; Table 1). Mechanical unloading and reverse LV remodeling was achieved within 6 to 9 months of LVAD support in all patients, as evidenced by reductions in LV short-axis and long-axis dimensions, decreases in mitral annular diameter, and increases in LV ejection fraction (Table 1).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
